300519 新光藥業
按盤價 
11.180 +0.570 (+5.372%)
11.180 +0.570 (+5.372%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.669 | 7.558 | 12.764 | 13.660 | 12.170 |
| 總資產報酬率 ROA (%) | 2.435 | 6.817 | 11.514 | 12.536 | 11.299 |
| 投入資產回報率 ROIC (%) | 2.657 | 7.534 | 12.721 | 13.613 | 11.910 | 邊際利潤分析 |
| 銷售毛利率 (%) | 37.528 | 41.274 | 51.853 | 55.705 | 55.301 |
| 營業利潤率 (%) | 25.867 | 27.416 | 36.019 | 41.319 | 39.739 |
| 息稅前利潤/營業總收入 (%) | 24.169 | 20.070 | 32.956 | 35.951 | 36.073 |
| 淨利潤/營業總收入 (%) | 22.707 | 23.800 | 30.960 | 35.615 | 34.964 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 93.134 | 91.070 | 96.510 | 95.324 | 91.167 |
| 價值變動淨收益/利潤總額(%) | 4.184 | 5.567 | 3.436 | 4.863 | 5.742 |
| 營業外收支淨額/利潤總額(%) | 0.694 | -1.330 | -0.797 | -0.474 | 2.006 | 償債能力分析 |
| 流動比率 (X) | 11.543 | 10.186 | 9.192 | 10.448 | 14.201 |
| 速動比率 (X) | 10.816 | 9.260 | 8.670 | 9.826 | 13.381 |
| 資產負債率 (%) | 8.275 | 9.274 | 10.322 | 9.243 | 7.167 |
| 帶息債務/全部投入資本 (%) | -0.435 | -0.790 | -0.878 | -0.950 | -- |
| 股東權益/帶息債務 (%) | -22,856.299 | -12,626.621 | -11,355.291 | -10,495.163 | -9,644.372 |
| 股東權益/負債合計 (%) | 1,108.485 | 978.294 | 868.758 | 981.841 | 1,295.276 |
| 利息保障倍數 (X) | -12.865 | -2.873 | -11.862 | -6.950 | -8.052 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 7.941 | 22.496 | 20.345 | 19.610 | 0.000 |
| 存貨周轉天數 (天) | 87.226 | 133.264 | 98.820 | 113.577 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
